Today: 9 June 2026
Uber stock price forecast: Robotaxi debut, analyst targets and the next catalysts for UBER

Uber stock price forecast: Robotaxi debut, analyst targets and the next catalysts for UBER

New York, January 7, 2026, 15:28 EST — Regular session

  • Uber shares rose 0.7% as investors digested a CES robotaxi debut with Lucid and Nuro.
  • Wall Street is split on how fast robotaxis bite into Uber’s economics, with price targets still well above the market.
  • Traders are now looking to U.S. jobs data on Jan. 9 and Uber’s expected early-February earnings update.

Uber Technologies shares rose 0.7% to $86.10 on Wednesday after Uber and partners Lucid and Nuro debuted a production-intent robotaxi at CES, the Consumer Electronics Show, in Las Vegas. Uber, which sold its self-driving unit to Aurora Innovation in 2020, has since leaned on partnerships to bring robotaxis onto its app. The stock traded between $85.16 and $87.73.

The robotaxi push matters now because it puts a fresh question on Uber’s stock price forecast: how much of each fare Uber keeps when cars drive themselves. Melius Research cut Uber to “sell” on Jan. 5 and set a $73 price target, warning robotaxis from Tesla and Alphabet’s Waymo could force lower prices or thinner platform fees, Barron’s reported. Washington is also moving: a U.S. House panel plans a Jan. 13 hearing on draft proposals that could ease deployment hurdles for self-driving vehicles. Barron’s

Uber has not confirmed an earnings date, but Wall Street Horizon data put the next report on Feb. 4 before the bell. Investors will listen for comments on ride growth, margins and the “take rate” — the cut Uber keeps from each booking — plus any update on autonomous partnerships and rollout timing. Wall Street Horizon

Uber, Lucid and Nuro said autonomous on-road testing began in December, led by Nuro, as they work toward a planned service launch in the San Francisco Bay Area later in 2026. “Uber is proud to partner with Lucid and Nuro to bring a state-of-the-art robotaxi to market later this year,” said Sarfraz Maredia, Uber’s global head of autonomous mobility and delivery. Uber Investor Relations

Separately, Uber and TomTom said they renewed a deal that plugs TomTom maps and location services into Uber’s platform. “Accurate mapping is key to delivering a fast and intuitive experience,” Uber vice president of product Amit Fulay said in the statement. GlobeNewswire

Jefferies analyst John Colantuono urged investors to buy into recent weakness, arguing the market is overpricing the near-term hit from self-driving rivals. “We recommend buying UBER,” he wrote, adding that “AVs will have nearly zero impact on growth through 2027.” Jefferies pointed to Waymo’s growth and said even a target of 1 million paid rides a week by end-2026 would still be a small share of U.S. rideshare demand. Investing.com

Wolfe Research trimmed its Uber price target to $110 from $125 while keeping an Outperform rating, pointing to elevated valuations even as it expects 2026 to remain constructive for internet names. 

Across the Street, price targets still sit above the tape. MarketScreener data based on FactSet show an average target price of about $110.72, implying roughly 29% upside from recent levels, though estimates run from $73 to $150. 

But the downside case is simple: robotaxis scale faster than expected, regulators clear the path sooner, and Uber’s take rate compresses as it competes to keep riders and fleets on its platform. Barchart data show Uber is about 15% below its 52-week high of $101.99; short-term traders have also been watching the mid-$80s area after Wednesday’s dip and rebound.

Macro data could still set the tone before company news hits. Investors are waiting for the U.S. government’s December jobs report on Friday, Jan. 9, after mixed labor-market signals on Wednesday; Uber’s next major company catalyst remains its expected early-February earnings update. 

Stock Market Today

  • Wheat Futures Rise as Export Inspections Show Mixed Data
    June 9, 2026, 9:19 AM EDT. Wheat futures gained on Monday, with Chicago SRW up 5-7 cents, KC HRW up 9-11 cents, and MPLS spring wheat rising slightly. Export inspections reported 319,730 MT shipped in the week ending June 4, down 20.65% from the previous week and 1.38% below last year. Mexico led exports with 83,211 MT. Managed money increased net shorts in Chicago wheat futures to 57,871 contracts, hitting a record bear move since 2006. Ukraine's wheat crop estimate rose 1.8 MMT to 21.7 MMT. July 26 CBOT Wheat futures closed at $5.86 ½, up 6 ½ cents, reflecting bullish momentum amid volatile trading conditions.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Europa Clipper’s UV look at Comet 3I/ATLAS backs water-ice call as radio “technosignature” scan finds none
Previous Story

Europa Clipper’s UV look at Comet 3I/ATLAS backs water-ice call as radio “technosignature” scan finds none

AMD stock slips after hours as CES AI chip blitz sets up Feb. 3 earnings test
Next Story

AMD stock slips after hours as CES AI chip blitz sets up Feb. 3 earnings test

Go toTop